Review of radiofrequency ablation for renal cell carcinoma

Clinical Cancer Research

Volumn 10, Issue 18 II, 2004, Pages

  Hines Peralta, Andrew ^a   Goldberg, S Nahum ^a,b   Novick, Andrew ^c   Figlin, Robert ^c   Stadler, Walter ^c   Gordon, Michael ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC TRIOXIDE;

ASPIRATION PNEUMONIA; CATHETER ABLATION; COMORBIDITY; COMPARATIVE STUDY; CONFERENCE PAPER; DEVICE; DRUG MECHANISM; ELECTRODE; HEAT TREATMENT; HEATING; HEMATURIA; HUMAN; HYDRONEPHROSIS; HYPERTHERMIC THERAPY; KIDNEY BLOOD FLOW; KIDNEY CARCINOMA; KIDNEY PARENCHYMA; LIVER TUMOR; MORBIDITY; MORTALITY; NEEDLE; NONHUMAN; PATIENT SELECTION; PRIORITY JOURNAL; TEMPERATURE DEPENDENCE; THERMAL INJURY; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME; TUMOR BLOOD FLOW; URETER STRICTURE; VON HIPPEL LINDAU DISEASE;

CARCINOMA, RENAL CELL; CATHETER ABLATION; HUMANS; KIDNEY NEOPLASMS; RADIO WAVES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 4644332013     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-050004     Document Type: Conference Paper

References (59)

1. Solbiati L, Livraghi T, Goldberg SN, et al. Percutaneous radiofrequency ablation of hepatic metastases from colorectal cancer: long term results in 117 patients. Radiology 2001;221:159-66.
2. Goldberg SN, Gazelle GS, Compton CC, Mueller PR, Tanabe KK. Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation. Cancer (Phila) 2000;88:2452-63.
3. Rossi S, Buscarini E, Garbagnati F, et al. Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode. AJR Am J Roentgenol 1998;170:1015-22.
4. Curley SA, Izzo F, Ellis LM, Nicolas Vauthey J, Vallone P. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 2000;232:381-91.
5. Livraghi T, Goldberg SN, Lazzaroni S, et al. Small hepatocellular carcinoma: treatment with radiofrequency ablation versus ethanol injection. Radiology 1999;210:655-61.
6. Livraghi T, Meloni F, Goldberg SN, et al. Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology 2000;214:761-8.
7. Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR. Renal cell carcinoma: clinical experience and technical success with radio-frequency ablation of 42 tumors. Radiology 2003;226:417-24.
8. Pavlovich CP, Walther MM, Choyke PL, et al. Percutaneous radio frequency ablation of small renal tumors: initial results. J Urol 2002;167:10-5.
9. Su LM, Jarrett TW, Chan DY, Kavoussi LR, Solomon SB. Percutaneous computed tomography-guided radiofrequency ablation of renal masses in high surgical risk patients: preliminary results. Urology 2003;61(Suppl 1):26-33.
10. Farrell MA, Charboneau WJ, DiMarco DS, et al. Imaging-guided radiofrequency ablation of solid renal tumors. AJR Am J Roentgenol 2003;180:1509-13.
11. Mayo-Smith WW, Dupuy DE, Parikh PM, Pezzullo JA, Cronan JJ. Imaging-guided percutaneous radiofrequency ablation of solid renal masses: techniques and outcomes of 38 treatment sessions in 32 consecutive patients. AJR Am J Roentgenol 2003;180:1503-8.
12. Roy-Choudhury SH, Cast JE, Cooksey G, Puri S, Breen DJ. Early experience with percutaneous radiofrequency ablation of small solid renal masses. AJR Am J Roentgenol 2003;180:1055-61.
13. Ogan K, Jacomides L, Dolmatch BL, et al. Percutaneous radiofrequency ablation of renal tumors: technique, limitations, and morbidity. Urology 2002;60:954-8.
14. Jeffrey SS, Birdwell RL, Ikeda DM, et al. Radiofrequency ablation of breast cancer: first report of an emerging technology. Arch Surg 1999;134:1064-8.
15. Rosenthal DI, Hornicek FJ, Wolfe MW, et al. Changes in the management of osteoid osteoma. J Bone Joint Surg 1998;80:815-21.
16. Dupuy DE, Safran H, Mayo-Smith WW, Goldberg SN. Radiofrequency ablation of painful osseous metastases. Radiology 1998;209:389.
17. Callstrom MR, Charboneau JW, Goetz MP, et al. Painful metastases involving bone: feasibility of percutaneous CT- and US-guided radiofrequency ablation. Radiology 2002;224:87-97.
18. Sewell PE, Jackson MD, Vance RB, Wang YD. Assessing radiofrequency ablation of non-small cell lung cancer with positron emission tomography. Radiology 2000;217:551.
19. Lewin JS, Connell CF, Duerk JL, et al. Interactive MRI guided RF interstitial thermal ablation of abdominal tumors: clinical trial for evaluation of safety and feasibility. J Magn Reson Imaging 1998;8:40-7.
20. Dupuy DE, Monchik JM, Decrea C, Pisharodi L. Radiofrequency ablation of regional recurrence from well-differentiated thyroid malignancy. Surgery 2001;130:971-7.
21. Abraham J, Fotjo T, Wood BJ. Radiofrequency ablation of metastatic lesions in adrenocortical cancer. Ann Intern Med 2000;133:312-3.
22. Wood BJ, Bates S. Radiofrequency thermal ablation of a splenic metastasis. J Vasc Interv Radiol 2001;12:261-3.
23. Djavan B, Zlotta AR, Susani M, et al. Transperineal radiofrequency interstitial tumor ablation of the prostate: correlation of magnetic resonance imaging with histopathologic examination. Urology 1997;50:986-93.
24. Zlotta AR, Djavan B, Matos C, et al. Percutaneous transperineal radiofrequency ablation of prostate tumor: safety, feasibility, and pathological effect on human prostate cancer. Br J Urol 1998;81:265-75.
25. Pacak K, Fojo T, Goldstein DS, et al. Radiofrequency ablation (RFA): a novel approach for the treatment of metastatic pheochromocytoma. J Natl Cancer Inst (Bethesda) 2001;93:648-9.
26. American Cancer Society. Cancer Facts and Figures, 2003. Atlanta, GA: American Cancer Society; 2003.
27. Zagoria RJ. Imaging of small renal masses: a medical success story. AJR Am J Roentgenol 2000;175:945-55.
28. Jayson M, Sanders H. Increased incidence of serendipitously discovered renal cell carcinoma. Urology 1998;51:203-5.
29. Messerli FH, Grossman E. Management of small renal tumors: an overview. Am J Med 2001;110:558-62.
30. Kassouf W, Aprikian AG, Laplante M, Tanguay S. Natural history of renal masses followed expectantly. J Urol 2004;171:111-3.
31. Gervais DA, McGovern FJ, Wood BJ, et al. Radio-frequency ablation of renal cell carcinoma: early clinical experience. Radiology 2000;217:665-72.
32. Walther MC, Shawker TH, Libutti SK, et al. A phase 2 study of radio frequency interstitial tissue ablation of localized renal tumors. J Urol 2000;163:1424-7.
33. Zagoria RJ, Chen MY, Kavanagh PV, Torti FM. Radio frequency ablation of lung metastases from renal cell carcinoma. J Urol 2001;166:1827-8.
34. Kavolius JP, Mastorakos DP, Palovick C, et al. Resection of metastatic renal cell carcinoma. J Clin Oncol 1998;16:2261-6.
35. Plutz S, Meimarakis G, Wichmann MW, et al. Long-term results after pulmonary resection of renal cell carcinoma metastases. Ann Thorac Surg 2002;73:1082-7.
36. Goldberg SN, Dupuy DE. Image-guided radiofrequency tumor ablation: challenges and opportunities: part I. J Vasc Interv Radiol 2001;12:1021-32.
37. Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol 2000;174:323-31.
38. Gillams AR, Lees WR. Survival after percutaneous, image-guided, thermal ablation of hepatic metastases from colorectal cancer. Dis Colon Rectum 2000;43:656-61.
39. Goldberg SN, Stein M, Gazelle GS, et al. Percutaneous radiofrequency tissue ablation: optimization of pulsed-RF technique to increase coagulation necrosis. J Vasc Interv Radiol 1999;10:907-16.
40. Goldberg SN, Solbiati L, Hahn PF, et al. Large-volume tissue ablation with radiofrequency by using a clustered, internally-cooled electrode technique: laboratory and clinical experience in liver metastases. Radiology 1998;209:371-9.
41. Meloni MF, Goldberg SN, Livraghi T, et al. Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Hoppler sonography, and helical CT. AJR Am J Roentgenol 2001;177:375-80.
42. Michaels MJ, Rhee HK, Mourtzinos AP, et al. Incomplete renal tumor destruction using radiofrequency interstitial ablation. J Urol 2002;168:2406-9.
43. Matlaga BR, Zagoria RJ, Woodruff RD, Torti FM, Hall MC. Phase II trial of radiofrequency ablation of renal cancer: evaluation of the kill zone. J Urol 2002;168:2411-2.
44. Marcovich R, Aldana JP, Morgenstern N, et al. Optimal lesion assessment following acute radiofrequency ablation of porcine kidney: cellular viability or histopathology. J Urol 2003;170:1370-4.
45. McGovern FJ, Wood BJ, Goldberg SN, Mueller PR. Radiofrequency ablation of renal carcinoma via image guided needle electrodes. J Urol 1999;161:599-600.
46. Hall WH, McGahan JP, Link DP, DeVere White RW. Combined embolization and percutaneous radiofrequency ablation of a solid renal tumor. AJR Am J Roentgenol 2000;174:1592-4.
47. Hwang JJ, Walther MM, Pautler SE, et al. Radio frequency ablation of small renal tumors: intermediate results. J Urol 2004;171:1814-8.
48. Johnson DB, Saboorian MH, Duchene DA, Ogan K, Cadeddu JA. Nephrectomy after radiofrequency ablation-induced ureteropelvic junction obstruction: potential complication and long-term assessment of ablation adequacy. Urology 2003;62:351-2.
49. de Baere T, Risse O, Kuoch V, et al. Adverse events during radiofrequency treatment of 582 hepatic tumors. AJR Am J Roentgenol 2003;18:695-700.
50. Wood BJ, Grippo J, Pavlovich CP. Percutaneous radio frequency ablation for hematuria. J Urol 2001;166:2303-4.
51. McLaughlin CA, Chen MY, Torti FM, Hall MC, Zagoria RJ. Radiofrequency ablation of isolated local recurrence of renal cell carcinoma after radical nephrectomy. AJR Am J Roentgenol 2003;181:93-4.
52. Friedel G, Hurtgen M, Penzenstadler M, Kyriss T, Toomes H. Resection of pulmonary metastases from renal cell carcinoma. Anticancer Res 1999;19:1593-6.
53. Patterson EJ, Scudamore CH, Owen DA, Nagy AG, Buczkowski AK. Radiofrequency ablation of porcine liver in vivo: effects of blood flow and treatment time on lesion size. Ann Surg 1998;227:559-65.
54. Lu DS, Raman CC, Vodopich DJ, et al. Effect of vessel size on creation of hepatic radiofrequency lesions in pigs: assessment of the "heat sink" effect. AJR Am J Roentgenol 2002;187:47-51.
55. Rossi S, Garbagnati F, Lencioni R, et al. Percutaneous radiofrequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology 2000;217:119-26.
56. Gee MS, Saunders HM, Lee JC, et al. Doppler ultrasound imaging detects changes in tumor perfusion during antivascular therapy associated with vascular anatomic alterations. Cancer Res 2001;61:2974-82.
57. Murgo AJ. Clinical trials of arsenic trioxide in hematologic and solid tumors: overview of the National Cancer Institute cooperative research and development studies. Oncologist 2001;6:22-8.
58. Horkan C, Ahmed M, Liu Z, et al. Radiofrequency ablation: effect of pharmacologic modulation of hepatic and renal blood flow on coagulation diameter in a VX2 tumor model. J Vasc Interv Radiol 2004;15:269-74.
59. Zagoria RJ, Hawkins AD, Clark PE, et al. Percutaneous CT-guided radiofrequency ablation of renal neoplasms: factors influencing success. AJR Am J Roentgenol 2004;183:201-7.